* Harrow Health Inc HROW.OQ reported a quarterly adjusted
loss
of 14 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 4 cents per share.
* Revenue rose 43.5% to $33.47 million from a year ago;
analysts
expected $31.04 million.
* Harrow Health Inc's reported EPS for the quarter was a
loss
of 14 cents.
* The mean earnings estimate of analysts had fallen by
about 1,101.2% in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* Harrow Health Inc shares had risen by 6.4% this
quarter and
gained 37.3% so far this year.
* The company reported a quarterly loss of $4.23 million.
* Wall Street's median 12-month price target for Harrow
Health Inc
is $37.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 9 at 09:03 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.04 -0.14 Missed
Mar. 31 2023 -0.05 -0.22 Missed
Dec. 31 2022 -0.12 0.04 Beat
Sep. 30 2022 0.00 -0.24 Missed